Nilfisk Holding A/S
Revised full-year 2025 outlook
Revised full-year 2025 outlook
US market activity and, as a result, order intake in Nilfisk’s US business has not improved as expected in November and the beginning of December. In addition, short-term issues with one supplier have limited the capacity to ship full volume of two products, before year-end. As a result, Nilfisk now expects organic growth for 2025 in the range of 0–1%. Nilfisk continues to expect an EBITDA margin before special items of 13%-14% including profit contribution from associates.
| New outlook December 11, 2025 | Previous outlook November 20, 2025 | |
| Organic revenue growth | 0% to 1% | Around 1% |
| EBITDA margin before special items | 13%-14% | 13% to 14% |
Contact
Nynne Jespersen Lee, Head of IR & Group Communications, +45 4231 0007
Forward-looking statements
Statements made about the future in this report reflect the Executive Management Board’s current expectations with regard to future events and financial results. Statements about the future are by their nature subject to uncertainty, and the results achieved may therefore differ from expectations, due to economic and financial market developments, legislative and regulatory changes in markets that the Nilfisk Group operates in, development in product demand, competitive conditions, energy and raw material prices, and other risk factors. Nilfisk Holding A/S disclaims any liability to update or adjust statements about the future or the possible reasons for differences between actual and anticipated results except where required by legislation or other regulations.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SkiStar AB13.12.2025 16:00:00 CET | Press release
Bulletin from Annual General Meeting of SkiStar AB
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom